Biospectronics Private Limited
Biospectronics aims to address significant limitations in existing biochemistry analyzers, which are vital for diagnosing a wide range of diseases through blood serum analysis.
Current analyzers suffer from complex, costly electromechanical hardware, import dependency, contamination risks due to shared flow cells, and a tendency for false readings. By developing a more reliable, cost-effective, and accurate solution, this team seeks to revolutionize blood parameter detection, enhancing both diagnostic precision and accessibility in healthcare.